Literature DB >> 3459716

Characteristics of a cell line established from a patient with multiple osteosarcoma, appearing 13 years after treatment for bilateral retinoblastoma.

O Fodstad, A Brøgger, O Bruland, O P Solheim, J M Nesland, A Pihl.   

Abstract

An osteosarcoma cell line, OHS, was established from a patient with multiple skeletal manifestations of osteosarcoma, developing after bilateral retinoblastoma. The tumor cells expressed sarcoma-associated antigens and showed rapid growth in monolayers and as multicellular spheroids. They formed distinct colonies in soft agar, and subcutaneous tumors in nude mice. Morphological studies indicated that OHS cells had retained important characteristics of the cells of origin. No deletion of the retinoblastoma genes on chromosome 13q14 could be demonstrated with the banding techniques used. However, cytogenetic studies revealed double minute chromosomes, as evidence of gene amplification, as well as translocations involving chromosomes 1,6,11 and 13. The OHS line can be used to study the genetic basis of tumor initiation and growth, and to elucidate factors predisposing for second primary cancers in retinoblastoma patients.

Entities:  

Mesh:

Year:  1986        PMID: 3459716     DOI: 10.1002/ijc.2910380107

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  22 in total

1.  IL-6 and CXCL8 mediate osteosarcoma-lung interactions critical to metastasis.

Authors:  Amy C Gross; Hakan Cam; Doris A Phelps; Amanda J Saraf; Hemant K Bid; Maren Cam; Cheryl A London; Sarah A Winget; Michael A Arnold; Laura Brandolini; Xiaokui Mo; John M Hinckley; Peter J Houghton; Ryan D Roberts
Journal:  JCI Insight       Date:  2018-08-23

2.  Multi-modal characterization of vasculature and nanoparticle accumulation in five tumor xenograft models.

Authors:  Einar Sulheim; Jana Kim; Annemieke van Wamel; Eugene Kim; Sofie Snipstad; Igor Vidic; Ingeborg Hovde Grimstad; Marius Widerøe; Sverre H Torp; Steinar Lundgren; David J Waxman; Catharina de Lange Davies
Journal:  J Control Release       Date:  2018-04-21       Impact factor: 9.776

3.  An adenovirus E1A transcriptional repressor domain functions as an activator when tethered to a promoter.

Authors:  M Bondesson; M Mannervik; G Akusjärvi; C Svensson
Journal:  Nucleic Acids Res       Date:  1994-08-11       Impact factor: 16.971

4.  Characterization of tumor microvascular structure and permeability: comparison between magnetic resonance imaging and intravital confocal imaging.

Authors:  Nina Kristine Reitan; Marte Thuen; Pål Erik Goa; Catharina de Lange Davies
Journal:  J Biomed Opt       Date:  2010 May-Jun       Impact factor: 3.170

5.  The metalloproteinase inhibitor TIMP-2 is down-regulated by androgens in LNCaP prostate carcinoma cells.

Authors:  Ase Bratland; Erlend Ragnhildstveit; Kristin Bjørnland; Kristin Andersen; Gunhild Mari Maelandsmo; Oystein Fodstad; Fahri Saatcioglu; Anne Hansen Ree
Journal:  Clin Exp Metastasis       Date:  2003       Impact factor: 5.150

6.  Osteoblast-induced EGFR/ERBB2 signaling in androgen-sensitive prostate carcinoma cells characterized by multiplex kinase activity profiling.

Authors:  Ase Bratland; Piet J Boender; Hanne K Høifødt; Ingrid H G Østensen; Rob Ruijtenbeek; Meng-Yu Wang; Jens P Berg; Wolfgang Lilleby; Øystein Fodstad; Anne Hansen Ree
Journal:  Clin Exp Metastasis       Date:  2009-03-18       Impact factor: 5.150

7.  Signal transduction mechanisms involved in S100A4-induced activation of the transcription factor NF-kappaB.

Authors:  Ida Grotterød; Gunhild M Maelandsmo; Kjetil Boye
Journal:  BMC Cancer       Date:  2010-05-28       Impact factor: 4.430

8.  A novel human recombinant single-chain antibody targeting CD166/ALCAM inhibits cancer cell invasion in vitro and in vivo tumour growth.

Authors:  Merete Thune Wiiger; Hege B Gehrken; Øystein Fodstad; Gunhild M Maelandsmo; Yvonne Andersson
Journal:  Cancer Immunol Immunother       Date:  2010-07-16       Impact factor: 6.968

9.  Nude rat models for human tumor metastasis to CNS. Procedures for intracarotid delivery of cancer cells and drugs.

Authors:  A T Myklebust; A Helseth; K Breistøl; W A Hall; O Fodstad
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

10.  S100A4 regulates membrane induced activation of matrix metalloproteinase-2 in osteosarcoma cells.

Authors:  Berit Mathisen; Rune I Lindstad; Janne Hansen; Sara Ann El-Gewely; Gunhild M Maelandsmo; Eivind Hovig; Oystein Fodstad; Thrina Loennechen; Jan-Olof Winberg
Journal:  Clin Exp Metastasis       Date:  2003       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.